• Skip to main content
  • Skip to footer
cnb1439_3rs-project_nav-ad_v1
  • About us
  • News
  • Events
  • Careers
cn-bio-organ-on-a-chip-logo
  • Products
    • PhysioMimix® OOC Microphysiological Systems
    • Consumables
      • PhysioMimix® multi-chip plates
      • 3D validated cells
      • NASH-in-a-box
    • Organ-on-a-chip models
    • Gut/Liver-on-a-chip
    • Lung-on-a-chip
    • Support packages
  • Applications
    • Disease modeling
    • Safety toxicology
    • ADME
  • Services
    • Non-Alcoholic Steatohepatitis
    • Drug-Induced Liver Injury
    • ADME
  • Technology
  • Resources
  • Company
    • About us
    • Events
    • News
    • Careers in Biotech
  • Contact us

Explore our solutions


PhysioMimix® is a suite of hardware, consumables and assay protocols that enable you to recreate complex human biology and accurately predict human drug responses.

PhysioMimix OOC

physiomimix-single-and-multi-organ-on-a-chip-systems
Learn more

Consumables

Multi-chip plates
3D validated cells
NASH-in-a-box
Bioavailability assay kit: Human 18
DILI assay kit: Human 24
Learn more

Models

Single-organ models
- Liver-on-a-chip model
- Lung-on-a-chip model
Multi-organ models
- Gut/Liver-on-a-chip models

Support packages

PhysioMimix® support packages

Discover the applications


Investigate the application areas that our PhysioMimix® products and services support

Learn more

Disease modeling

Metabolic dysfunction-associated steatohepatitis
Hepatitis B
Pulmonary infection
Learn more

Safety toxicology

Drug-induced liver injury
Immune-mediated liver injury
Learn more

ADME

Drug absorption
Drug metabolism
Drug bioavailability
Oligonucleotide delivery
Learn more

Studies as a service


Our team will work collaboratively with you to design a study around your research goals and generate actionable data within weeks

Learn more
icon-nash-1-150x150.png MASLD/MASH
icon-dili-tox-150x150.png Drug-induced liver injury
icon-adme-150x150.png ADME

Organ-on-a-Chip Resources

Resource type

Area of interest

Videos and animations

Resource image

PhysioMimix® cross-species DILI CRS for enhanced IVIVE

Gain clarity, confidence, speed, and enhance your ethical responsibility by leveraging our cross-species Drug-induced liver injury assays (human, rat and dog) in your drug discovery or development workflow. Improve your in vitro to in vivo extrapolation (IVIVE) capabilities today via our DILI Contract Research Service.

Blogs

Resource image

CN Bio to participate in 3Rs Collaborative-lead project with FDA to build confidence in Liver MPS for DILI

Building Confidence in MPS for Regulatory Applications!

Brochures & Flyers

Resource image

PhysioMimix DILI assay kit: Human 24 brochure

Predict more complex, latent and immune-related hepatotoxicity in vitro. The PhysioMimix DILI assay kit contains everything you need to recreate our FDA-recognized assay in your own laboratory.

Webinars

Resource image

Harnessing Liver-on-a-chip models for drug safety

Webinar Series 8 Episode 2

Discover how to leverage human and animal Liver-on-a-chip (aka Liver microphysiological systems) in toxicology studies to enhance data translatability between preclinical testing and clinical applications.

Featuring industry experts from CN Bio and Bristol Myers Squibb.

Articles

Resource image

How OOC can improve in vitro to in vivo translatability of preclinical data

Videos and animations

Resource image

PhysioMimix® DILI assay kit: Human 24 for deeper mechanistic hepatotoxicity insights

Confidently predict DILI with PhysioMimix DILI assay kit: Human 24-accurate, human-relevant mechanistic hepatotoxicity insights to enhance drug safety in development

Articles

Resource image

Addressing the challenges of developing new modality drugs

Discover how new modality drugs are revolutionizing medicine by targeting complex diseases with cutting-edge therapies. Learn about the challenges, innovative solutions, and the role of AI and Organ-on-a-chip (OOC) technology in new modality drug development. Expert insights.

Posters

Resource image

A human liver microphysiological system for assessing mechanisms of toxicity during drug development

Understand the advantages of using OOC to derive human translatable mechanistic insights ahead of more costly drug development phases.

Articles

Resource image

How Organ-on-a-chip can reduce DILI risk in drug development

Drug-induced Liver injury is a common cause of drug withdrawal during late drug development as well as post-approval. The liver, a primary site of drug metabolism, is particularly susceptible. However, DILI can occur through several pathways, each involving different mechanisms.

This article explores why traditional in vitro and in vivo animal studies are less able to predict more complex indirect or idiosyncratic effects that are latent in onset and how preclinical workflows can be modernized to reduce risk through Organ-on-a-chip’s mechanistic insights.

Application notes

Resource image

Evaluating a human DILI assay kit’s ability to unlock complex mechanisms of toxicity

Here, we demonstrate how the PhysioMimix DILI assay kit: Human 24 and PhysioMimix OOC Single-organ System captures more complex mechanisms of human DILI than traditional preclinical approaches to reduce the risk of unforeseen event detection in the clinic.

Articles

Resource image

Scrip Asks… What Does 2025 Hold For Biopharma?

Part 6: Therapeutic Area Advances

In part 6 of this Scrip Asks series, Dr. Tomasz Kostrzewski, joins 40 other biopharma leaders, who share their views on the upcoming developments in key therapeutic areas to look out for. They also discuss multiple scientific fields that are opening up new avenues for treatment.

Webinars

Resource image

Go/No-Go

Webinar Series 7 Episode 3

In this webinar “Go/No-Go” we demonstrate how to further de-risk development workflows with the PhysioMimix® DILI assay. Using drugs that were identified as toxic in the clinic, we reveal some of the data-rich investigative toxicology studies that can be achieved using a human liver microphysiological system (MPS), otherwise known as organ-on-a-chip (OOC).

Speak to our experts

Request a meeting with one of our OOC experts to see how our products and services can support your studies

Request a meeting

Footer

CN Bio logo

332 Cambridge Science Park, Milton Road
Cambridge, CB4 0WN

UK: +44 (0) 1223 737 941

US: +1 415 523 4005

Privacy | Cookies | Regulatory | Accessibility
Website terms | Terms of sale

Product Recycling

©2025 CN Bio Innovations Ltd
Registered No. ‍06517359. VAT No. GB978184563

Latest news

  • Integrating In Silico Tools with Organ-on-a-Chip to advance ADME studies July 15, 2025
  • NIH to prioritize human-based research technologies & reduce animal use in research July 7, 2025
  • CN Bio to participate in 3Rs Collaborative-lead project with FDA to build confidence in Liver MPS for DILI June 25, 2025
Cyber Essentials Logo